Subspecialty	Liver Transplantation
Clinical Interests	Hepatology
	Pediatrics
Languages	English
	Indian (Hindi)
	Spanish
Gender	Female
E-mail	nanda.kerkar@mountsinai.org
Education and Training	MBBS, Medical College of Bengal
	Residency, Gastroenterology, Royal Free Hospital Sch of Medicine
	Residency, Pediatrics, BJM Hospital for Children
	Residency, Pediatrics, Hospitals in South-East England
	Internship, Internal Medicine, Topiwala National Medical College
	Fellowship, Pediatrics, University of London (King's College)
	Fellowship, Pediatrics, University of London (King's College)
	Fellowship, Pediatric Gastroenterology, University of London (King's College)
	Fellowship, Hepatology, University of London (King's College)

Dr. Kerkar's areas of interest are autoimmune hepatitis including de novo autoimmune hepatitis following transplantation, viral hepatitis, nonalcoholic fatty liver disease and investigating adherence to medical regimes in children.

Dr. Kerkar completed her undergraduate schooling and medical education in Calcutta, India. She was awarded The Children Nationwide Research Scholarship in 1996 by the Royal college of Physicians and completed two years of basic research training in Immunology at University College, London. She then completed the equivalent of board certification in pediatrics and pediatric Gastroenterology/Hepatology at King's College Hospital in London, England.

Among Dr. Kerkar's many society memberships are the American Association of the Study of Liver Disease, American Society of Transplant surgeons, International Pediatric Transplantation Society and North American society of Pediatric Gastroenterology, Hepatology and Nutrition.

Dr. Kerkar is the PI for studying 'Adefovir in children with chronic hepatitis B virus infection', 'Adherence to medications in children' and 'Newer immunosuppressive regimens in pediatric liver transplantation'. Her research efforts to date have mainly focused on autoimmune hepatitis. She is currently establishing protocols to study and manage children with nonalcoholic steatohepatitis (NASH) and chronic hepatitis B virus infection.

Education and Training	MBBS, Medical College of Bengal
	Residency, Gastroenterology, Royal Free Hospital Sch of Medicine
	Residency, Pediatrics, BJM Hospital for Children
	Residency, Pediatrics, Hospitals in South-East England
	Internship, Internal Medicine, Topiwala National Medical College
	Fellowship, Pediatrics, University of London (King's College)
	Fellowship, Pediatrics, University of London (King's College)
	Fellowship, Pediatric Gastroenterology, University of London (King's College)
	Fellowship, Hepatology, University of London (King's College)

Subspecialty	Liver Transplantation
Clinical Interests	Hepatology
	Pediatrics
Languages	English
	Indian (Hindi)
	Spanish

PI for Newer Immunosuppressive regimens in pediatric liver transplantation

This will be a retrospective review of the charts to ascertain indications for starting additional immunosuppressive agents, assess outcome of the liver graft and recipient on the new regime and thus enable tailoring of immunosuppression in complicated patients.

Kerkar N, Hadzic N , Davies ET, Portmann B , Donaldson PT, Rela M , Heaton ND, Vergani D , Mieli-Vergani D . De-novo autoimmune hepatitis after liver transplantation. Lancet 1998 Feb; 351(9100): 409-13.

Kerkar N, Ma Y, Hussain M, Muratori L, Bianchi F, Mieli-Vergani G, Vergani D. A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of Liver Kidney Microsomal Antibody Type 1. Journal of Immunological Methods 1999; 223: 227-235.

Ma Y, Thomas MG, Okamoto M, Bogdanos DP, Nagl S, Kerkar N, Lopes AR, Muratori L, Lenzi M, Bianchi FB, Mieli-Vergani G, Vergani D. Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. Journal of Immunology 2002; 169: 277-285.

Shemesh E , Shneider BL, Savitzky JK, Arnott L , Gondolesi GE, Krieger NR, Kerkar N, Magid MS, Stuber ML, Schmeidler J , Yehuda R , Emre S . Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004 Apr; 113(4): 825-32.

Kerkar N. Non-alcoholic steatohepatitis in children. Pediatr Transplant 2004 Dec; 8(6): 613-8.

Kerkar N, Gold D , Thung SN, Shneider BL. Jaundice accompanied by giant cell hepatitis and eosinophilia in childhood. Semin Liver Dis 2004 Feb; 24(1): 107-11.

Kerkar N. Evaluating the AIH scoring system. J Pediatr Gastroenterol Nutr 2005 Jul; 41(1): 137-8.

Kerkar N. Hepatitis B in children: Complexities in management. Pediatr Transplant 2005 Oct; 9(5): 685-91.

Kerkar N, Dugan C , Rumbo C , Morotti RA, Shneider BL, Emre S . Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant 2005 May; 5(5): 1085-9.

Kerkar N, Shneider BL. Evolving approaches to the treatment of chronic hepatitis B virus infection in children [editorial]. J Clin Gastroenterol 2005 Jan; 39(1): 7-9.